Responses
Immune cell therapies and immune cell engineering
Original research
Association of bridging therapy utilization with clinical outcomes in patients receiving chimeric antigen receptor (CAR) T-cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.